The Added Value of Circulating Tumor Cell Enumeration to Standard Markers in Assessing Prognosis in a Metastatic Castration-Resistant Prostate Cancer Population
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-16-1224
Full Text
Open PDFAbstract
Available in full text
Date
September 27, 2016
Authors
Publisher
American Association for Cancer Research (AACR)